AI-generated summary
The authors report a case of a single cutaneous CD30-positive lymphoproliferative nodule treated with a 308-nm excimer laser, which they describe as successful. They suggest the laser may be a safe and well-tolerated option for localized lesions of this type. Because the report describes one patient, the abstract does not support general conclusions about effectiveness or safety.
- Who or what was studied
- One patient with a solitary primary cutaneous CD30+ lymphoproliferative nodule
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The report describes a single case, so the findings cannot be generalized.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.